Review Reports

Round 1

Reviewer 1 Report

The manuscript by Pavlenko et al is focused on the unravelling of the role of gamma-synuclein in dysregulation of intraocular pressure and glaucoma. The authors shown that gamma-synuclein can modulate the mechanism of pathology of glaucoma through effect on intraocular pressure via interaction with catecholamines (dopamine). This is interesting and novel manuscript and I have only minor comments. 

1. Abstract. "γ-synuclein is an aggregation-prone protein involved in neurodegenerative diseases." However, the role of this form of synuclein in the mechanism of neurodegeneration is disputable compare to alpha-synuclein. Considering this this abstract would be better without this statement.

2. Figure legends 2 and 3 needs some additional explanation.  

Author Response

Please see the attachment

Author Response File: Author Response.docx

Reviewer 2 Report

This is a well written and organized manuscript, in which, the authors demonstrated the presence of autoantibodies against γ-synuclein in 20% of the patients in the study.

 

  

 

Specific suggestions/comments raised by the reviewer:

 

Line 22: “glaucoma-related physiological changes” or “glaucoma-related pathophysiological changes” Please specify.

 

Line 85: Render “antihypertensive” as “ocular hypotensive”

 

Line 93: Provide an alternate rendering for “optical cornea”

 

Lines 134 – 135: It was previously established that general anesthesia does not affect the level of IOP in both γ-KO and WT mice. Previously established by whom and when…

 

What is the sample size of the experimental animals?

 

Line 158: Rearrange the order of these numbers.

 

Line 297: The authors should elaborate on these other forms of glaucoma in which autoantibodies against γ-synuclein are expressed as the manuscript appears to only address POAG.

 

Line 296: Can you offer any explanation as to why only 1 in 5 individuals with POAG had autoantibodies against γ-synuclein?

 

 

Author Response

Please see the attachment

Author Response File: Author Response.docx